KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 146 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 3.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $85,508 | -12.4% | 63,812 | +17.0% | 0.00% | – |
Q2 2023 | $97,629 | -41.9% | 54,541 | +26.2% | 0.00% | – |
Q1 2023 | $168,161 | +36.9% | 43,229 | +19.7% | 0.00% | – |
Q4 2022 | $122,829 | -35.7% | 36,126 | +3.5% | 0.00% | – |
Q3 2022 | $191,000 | +35.5% | 34,901 | +12.2% | 0.00% | – |
Q2 2022 | $141,000 | -39.2% | 31,095 | -1.4% | 0.00% | – |
Q1 2022 | $232,000 | +14.3% | 31,546 | -0.1% | 0.00% | – |
Q4 2021 | $203,000 | +2.0% | 31,568 | -7.6% | 0.00% | – |
Q3 2021 | $199,000 | -32.5% | 34,157 | +19.4% | 0.00% | – |
Q2 2021 | $295,000 | +54.5% | 28,606 | +57.3% | 0.00% | – |
Q1 2021 | $191,000 | -50.4% | 18,180 | -26.8% | 0.00% | – |
Q4 2020 | $385,000 | +79.1% | 24,830 | +69.2% | 0.00% | – |
Q3 2020 | $215,000 | -23.5% | 14,678 | -1.1% | 0.00% | – |
Q2 2020 | $281,000 | -82.6% | 14,837 | -82.3% | 0.00% | -100.0% |
Q1 2020 | $1,614,000 | -64.1% | 84,039 | -64.2% | 0.00% | 0.0% |
Q4 2019 | $4,498,000 | +67.4% | 234,619 | -16.0% | 0.00% | 0.0% |
Q3 2019 | $2,687,000 | +53640.0% | 279,365 | +143164.1% | 0.00% | – |
Q2 2015 | $5,000 | – | 195 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 7,180,700 | $137,941,000 | 10.27% |
Palo Alto Investors LP | 4,299,901 | $82,601,000 | 6.92% |
Fairmount Funds Management LLC | 562,351 | $10,803,000 | 6.55% |
Avoro Capital Advisors LLC | 7,000,000 | $134,470,000 | 4.54% |
Pinz Capital Management, LP | 8,820 | $1,694,000 | 4.44% |
Birchview Capital, LP | 148,000 | $2,843,000 | 2.52% |
Elk Creek Partners, LLC | 699,951 | $13,446,000 | 2.31% |
Parkman Healthcare Partners LLC | 215,802 | $4,146,000 | 1.92% |
EAM Global Investors LLC | 136,402 | $2,620,000 | 1.53% |
SPHERA FUNDS MANAGEMENT LTD. | 550,000 | $10,566,000 | 1.32% |